Drug Shortage Report for DILTIAZEM CD
Report ID | 65221 |
Drug Identification Number | 02445999 |
Brand name | DILTIAZEM CD |
Common or Proper name | DILTIAZEM CD |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | DORMANT |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-10-31 |
Actual start date | 2018-11-05 |
Estimated end date | 2019-05-31 |
Actual end date | 2019-05-31 |
Shortage status | Resolved |
Updated date | 2019-06-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-06-01 | English | Compare |
v9 | 2019-05-31 | French | Compare |
v8 | 2019-05-31 | English | Compare |
v7 | 2019-05-17 | French | Compare |
v6 | 2019-05-17 | English | Compare |
v5 | 2018-11-06 | French | Compare |
v4 | 2018-11-06 | English | Compare |
v3 | 2018-11-01 | English | Compare |
v2 | 2018-10-22 | French | Compare |
v1 | 2018-10-22 | English | Compare |
Showing 1 to 10 of 10